Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/archdischild-2021-323171 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chemokine receptor-directed imaging, prognostication, and treatment of abdominal aortic aneurysm: can we do it all with CXCR4?
Cardiovasc Res
January 2025
Department of Cardiac Surgery, Medical University of Vienna, Währinger Gürtel 18-20, Vienna A-1090, Austria.
Enhancing the Predictive Utility of MHR for Senile Osteoporosis: Unaddressed Considerations and Future Directions [Response to Letter].
Clin Interv Aging
December 2024
Fujian Key Laboratory of Vascular Aging, Department of Geriatrics, Fujian Institute of Geriatrics, Fujian Clinical Research Center for Senile Vascular Aging and Brain Aging, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China.
Obesity-Surgery is not the end.
World J Gastrointest Surg
December 2024
Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
In this editorial we comment on the article published in the recent issue of the . It investigates the potential mechanism of alcohol use disorder (AUD) following weight loss and its future prospects. We are particularly interested in this issue.
View Article and Find Full Text PDFAuthors' Reply to Noguchi et al. Comment on: "Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors Used in Patients with Diabetes and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database".
Clin Drug Investig
December 2024
Department of Hospital Pharmacy, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki City, Nagasaki Prefecture, 852-8501, Japan.
Role of locoregional therapy including liver transplantation in liver-only metastatic colorectal cancer: a review paper.
Expert Rev Anticancer Ther
January 2025
Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, SA, Australia.
Introduction: Resection of primary tumor and liver metastases is the gold standard for colorectal cancer with liver-only metastases (CRLM). Although treatment options have expanded to enable conversion of unresectable to resectable CRLM, about 40% of patients will have definitively unresectable disease. Major advances in surgical techniques, immunosuppressive protocols and patient selection criteria for liver transplantation have resulted in improved outcomes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!